Sigma Healthcare Limited (ASX:SIG)

ALERT: Price-sensitive ASX Announcement for SIG

Current share price for SIG : $2.800 -0.19 (-6.35%)⁺

Announcement

Half Year Accounts

Release

26 Feb 2026 8:23AM

Price at Release

$2.990

Full Release

Summary

Sigma Healthcare Limited reported a significant increase in revenue and profit for the half year ended 31 December 2025, with revenue rising to $5.5 billion and net profit after tax attributable to owners reaching $379.8 million. The company declared a 2.0 cent interim dividend per share, fully franked, and maintained a strong equity position of $4.89 billion. Operations are spread across Australia and several international markets, with a noted merger with Chemist Warehouse contributing to non-recurring costs. Compliance with the Corporations Act 2001 was confirmed, alongside adherence to professional conduct codes.

Key Points

Revenue for the half year was $5.5 billion with a significant increase from the previous year's $1.96 billion.
Gross profit stood at $1,007.8 million, showing a substantial increase.
Net profit after tax attributable to owners was $379.8 million, marking over 22% growth from the previous period.
Basic and diluted earnings per share rose to 3.3 cents from 3.1 cents.
The company declared an interim dividend of 2.0 cents per share, fully franked.
Total equity of the group increased to $4.89 billion, up from $4.66 billion.
The company operates in multiple regions including Australia, New Zealand, China, Ireland, and UAE.
Total liabilities amounted to $3.85 billion, slightly up from $3.63 billion.
The financial report confirms no contraventions of the Corporations Act 2001 or professional conduct codes.
A merger with Chemist Warehouse was completed, incurring non-recurring costs for integration.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.